Search this site
Embedded Files
Elizabeth Bugie
  • Home
  • Research
    • Scientific Contributions
    • Bugie's Publications
  • Historical Context
    • Selman A. Waksman
    • Albert Schatz
    • Streptomycin Timeline
  • Marginalization
  • Antibiotics
  • Acknowledgments
    • References
Elizabeth Bugie
  • Home
  • Research
    • Scientific Contributions
    • Bugie's Publications
  • Historical Context
    • Selman A. Waksman
    • Albert Schatz
    • Streptomycin Timeline
  • Marginalization
  • Antibiotics
  • Acknowledgments
    • References
  • More
    • Home
    • Research
      • Scientific Contributions
      • Bugie's Publications
    • Historical Context
      • Selman A. Waksman
      • Albert Schatz
      • Streptomycin Timeline
    • Marginalization
    • Antibiotics
    • Acknowledgments
      • References
Image from Carlos Espinoza Vásquez

Elizabeth Bugie played a critical role in the discovery of streptomycin, the first effective treatment for tuberculosis (Goff 2024; Streptomycin [date unknown]). Despite her contributions, she received limited recognition, while Selman Waksman was awarded the Nobel Prize in 1952 for the discovery of streptomycin (Nobel Prize 1952; Dees 2024).

Her exclusion raises important questions about how credit is assigned in science and how factors such as gender and academic position can influence recognition. The purpose of this website is to highlight Bugie's accomplishments as a scientist and towards the discovery of streptomycin, as well as describing her marginalization in the field. 

Early Life and Career

Elizabeth Bugie was born on October 5, 1920, in New Jersey, United States (FamilySearch [date unknown]). She was raised in a family that valued education, and her father encouraged her to develop curiosity and strong analytical thinking from an early age (Angelova 2018). Bugie studied microbiology at the New Jersey College for Women—now Rutgers University—and later continued as a masters student in the laboratory of Selman Waksman (Dees 2024).  

Following her graduate studies, Bugie continued working in antimicrobial research and later joined the pharmaceutical company, Merck, where she studied antibiotic activity against infectious diseases (Dees 2024). After her early research career, she married fellow microbiologist Francis Gregory and stepped away from laboratory work to raise a family, reflecting the limited opportunities and expectations for women in science at the time (Angelova 2018). She later returned to school to pursue studies in library science and died on April 10, 2001 in Pennsylvania (Angelova 2018; FamilySearch [date unknown]).  

Image from The Scientista Foundation

Her Research  (Angelova 2018)

During her graduate studies, Bugie conducted research on antibiotic-producing microorganisms, including work that contributed to her master’s thesis on antimicrobial substances. At the time, antibiotic research was rapidly advancing, particularly during the 1940s, when scientists were searching for new treatments for infectious diseases. Her early academic and research experiences positioned her at the center of one of the most important scientific discoveries of the 20th century, which would later shape the course of modern medicine. 

Click Here to Learn More About Bugie's Research

Click Here to Learn More About Antibiotics

Timeline (Shaughnessy et al 2022)

Click Here to Learn More About the Historical Context Surrounding Streptomycin

Why Does Elizabeth Bugie's Story Matter?

Gender Inequality 

in Science

Highlights how women's contributions were often overlooked

Click Here to Learn More

Image modified from Nature

The "Lone Genius" 

Myth

Challenges the idea that discoveries are made by only one individual

Click Here to Learn More

Image modified from Work It Daily 

Relevance 

Today

Connects her story to ongoing issues in scientific recognition

Click Here to Learn More

Image modified from Shutterstock

References

Angelova L. 2018 Aug 8. Elizabeth Bugie – the invisible woman in the discovery of streptomycin. The Scientista Foundation. http://www.scientistafoundation.com/35/post/2018/08/elizabeth-bugie-the-invisible-woman-in-the-discovery-of-streptomycin.html

Dees J. 2024 Oct 14. Elizabeth Bugie Gregory: A forgotten figure in streptomycin discovery. Joyful Microbe. https://joyfulmicrobe.com/elizabeth-bugie-gregory-streptomycin/

Elizabeth Bugie Gregory. [date unknown]. FamilySearch; [accessed Apr 6]. https://ancestors.familysearch.org/en/G39Y-L9V/elizabeth-bugie-gregory-1920-2001

Goff J. 2024 Mar 15. Women in the history of antimicrobial development. American Society for Microbiology; [accessed 2026 Apr 6]. https://asm.org:443/articles/2024/march/women-in-the-history-of-antimicrobial-development

Nobel Prize in Physiology or Medicine 1952. [date unknown]. NobelPrize.org; [accessed 2026 Apr 6]. https://www.nobelprize.org/prizes/medicine/1952/summary/ 

Shaughnessy M, Varela MF, Varela AF. 2022. The life and times of the world’s most famous female scientists. Nova Science Publishers.

Streptomycin. [date unknown]. Encyclopedia Britannica; [accessed 2026 Apr 6]. https://www.britannica.com/science/streptomycin

Authors: Shaylyn Belland, Jordan Fedorvich, Chloe Funnell and Chad Nichol 
University of Alberta, Augustana Campus

AUBIO 411 (Advanced Perspectives in Biology): Marginalized Biologist Website, Winter 2026
The University of Alberta, its buildings, labs and research stations are primarily located on the territory of Néhiyaw (Cree), Niitsitapi (Blackfoot), Métis, Nakoda (Stoney), Dene, Haudenosaunee (Iroquois) and Anishinaabe (Ojibway/Saulteaux), lands that are now known as part of Treaties 6, 7 and 8 and homeland of the Métis. The University of Alberta respects the sovereignty, lands, histories, languages, knowledge systems and cultures of all First Nations, Métis, and Inuit.
Report abuse
Page details
Page updated
Report abuse